Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Urine TMPRSS2:ERG gene fusion could be used for stratification of patients at higher risk for prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationNonparametrics: Statistical Methods Based on Ranks
Mergenthaler, M. J., & Lehmann, E. L. (1979) · Technometrics · doi:10.2307/1268531 · Cited by 3,329
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
Nilsson, J., Skog, J., Nordstrand, A., Baranov, V, Mincheva-Nilsson, L., Breakefield, X. O., & Widmark, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605058 · Cited by 776
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659
APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer
Groskopf, J., Aubin, S. M., Deras, I. L., Blase, A., Bodrug, S., Clark, C., Brentano, S., Mathis, J., Pham, J., Meyer, T., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063289 · Cited by 529
Self-citationDevelopment of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
King, J. C., Xu, J., Wongvipat, J., Hieronymus, H., Carver, B. S., Leung, D. H., Taylor, B. S., Sander, C., Cardiff, R. D., Couto, S. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.371 · Cited by 477
PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
Deras, I. L., Aubin, S. M. J., Blase, A., Day, J. R., Koo, S., Partin, A. W., Ellis, W. J., Marks, L. S., Fradet, Y., Rittenhouse, H., et al. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.038 · Cited by 453
Self-citationA First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3224 · Cited by 409
Self-citationETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Tomlins, S. A., Bjartell, A., Chinnaiyan, A. M., Jenster, G., Nam, R. K., Rubin, M. A., & Schalken, J. A. (2009) · European Urology · doi:10.1016/j.eururo.2009.04.036 · Cited by 381
Self-citationAntibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Park, K., Tomlins, S. A., Mudaliar, K. M., Chiu, Y.-L., Esgueva, R., Mehra, R., Suleman, K., Varambally, S., Brenner, J. C., MacDonald, T., et al. (2010) · Neoplasia · doi:10.1593/neo.10726 · Cited by 351
Self-citationHessels, D., Smit, F. P., Verhaegh, G. W., Witjes, J. A., Cornel, E. B., & Schalken, J. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0700 · Cited by 334
An updated catalog of prostate cancer predictive tools
Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G., & Kattan, M. W. (2008) · Cancer · doi:10.1002/cncr.23908 · Cited by 264
Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer
Laxman, B., Tomlins, S. A., Mehra, R., Morris, D. S., Wang, L., Helgeson, B. E., Shah, R. B., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2006) · Neoplasia · doi:10.1593/neo.06625 · Cited by 239
Self-citationFurusato, B., Tan, S.-H., Young, D., Dobi, A., Sun, C., Mohamed, A. A., Thangapazham, R., Chen, Y., McMaster, G., Sreenath, T., et al. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.23 · Cited by 236
Mosquera, J.-M., Mehra, R., Regan, M. M., Perner, S., Genega, E. M., Bueti, G., Shah, R. B., Gaston, S., Tomlins, S. A., Wei, J. T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2927 · Cited by 234
Self-citationHan, B., Mehra, R., Lonigro, R. J., Wang, L., Suleman, K., Menon, A., Palanisamy, N., Tomlins, S. A., Chinnaiyan, A. M., & Shah, R. B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.69 · Cited by 227
Self-citationMosquera, J.-M., Perner, S., Genega, E. M., Sanda, M., Hofer, M. D., Mertz, K. D., Paris, P. L., Simko, J., Bismar, T. A., Ayala, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5194 · Cited by 215
Self-citationZong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203 · cited 1×
“In vitro and in vivo functional studies have also demonstrated a functional role for TMPRSS2:ERG fusions in prostate cancer oncogenesis (13, 17, 19, 20).”
Current status and future perspectives
Bahey-El-Din, M., & Gahan, C. G. M. (2011) · Cited by 109
Ross, L. E., Berkowitz, Z., & Ekwueme, D. U. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2709 · Cited by 107
Rostad, K., Hellwinkel, O., Haukaas, S. A., HALVORSEN, O. J., Oyan, A. M., Haese, A., Budäus, L., ALBRECHT, H., Akslen, L. A., Schlomm, T., et al. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02517.x · Cited by 72
USE OF EXTENDED PATTERN TECHNIQUE FOR INITIAL PROSTATE BIOPSY
Siu, W., Dunn, R. L., Shah, R. B., & Wei, J. T. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165385.53652.7a · Cited by 67
Self-citation
Cited by
The landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738
“Over 68% (58,648) of genes were classified as lncRNAs, of which 79% (48,952) were previously unannotated.”
BackgroundSelf-citationThe Emergence of lncRNAs in Cancer Biology
Prensner, J. R., & Chinnaiyan, A. M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0209 · Cited by 1,770
Self-citationThe role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Self-citationThe emerging complexity of gene fusions in cancer
Mertens, F., Johansson, B., Fioretos, T., & Mitelman, F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3947 · Cited by 682
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003180 · Cited by 472
Self-citation
Metadata
- Authors
- Tomlins, S. A., Aubin, S. M. J., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., Penabella, Y., Day, J. R., Varambally, R., Han, B., Wood, D., Wang, L., Sanda, M. G., Rubin, M. A., Rhodes, D. R., Hollenbeck, B., Sakamoto, K., Silberstein, J. L., Fradet, Y., Amberson, J. B., Meyers, S., Palanisamy, N., Rittenhouse, H., Wei, J. T., Groskopf, J., & Chinnaiyan, A. M.
- Venue
- Science Translational Medicine
- Published
- 2011-08-03
- Volume
- 3
- Issue
- 94
- Pages
- 94ra72-94ra72
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2112044462
- Cited by
- 350
- References
- 32
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.